- Home
- RHI vs RLAY Comparison
RHI vs RLAY Comparison
Compare RHI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RHI | RLAY |
|---|---|---|
| Founded | 1948 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RHI | RLAY |
|---|---|---|
| Price | $26.08 | $12.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $30.33 | $19.50 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 8.68% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $5,378,506,000.00 | $15,355,000.00 |
| Revenue This Year | $1.27 | N/A |
| Revenue Next Year | $5.95 | $324.03 |
| P/E Ratio | $184.36 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $21.83 | $2.75 |
| 52 Week High | $46.69 | $17.32 |
Technical Indicators
Market Signals| Indicator | RHI | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 49.33 |
| Support Level | $25.93 | $11.75 |
| Resistance Level | $28.28 | $17.32 |
| Average True Range (ATR) | 1.35 | 0.92 |
| MACD | -0.15 | -0.15 |
| Stochastic Oscillator | 57.72 | 62.68 |
Price Performance
Historical ComparisonAbout RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.